Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Omnicell, Inc. (OMCL) Institutional Ownership & Insider Trading

305 institutions reported holding Omnicell, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 11 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OMCLOmnicell, Inc.Follow OMCL — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

305 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.1%.

Increased+110New+44Decreased-78Closed-16

Largest moves, shares (millions)

Nuveen+0.6MArrowstreet Capital,…+0.6MNomura Asset Management…+0.4MLazard Asset Management-1.4MSumitomo Mitsui Trust Group-1.4MMillennium Management-0.6M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.8Sep 24+0.4Dec 24+0.4Mar 25+0.2Jun 25-1.8Sep 25-0.0Dec 25+0.3Mar 26+1.5Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2630548+3.1%110447816
Mar 2627347+0.6%87358227
Dec 2526147-0.1%80338627
Sep 2525346-3.7%79299118
Jun 2524447+0.4%92227644
Mar 2527047+1.0%94278130
Dec 2427646+0.9%90406227
Sep 2425746-4.6%61439429

Omnicell, Inc. — questions

Who owns Omnicell, Inc. stock?
305 institutions reported Omnicell, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (6.9%), WELLINGTON MANAGEMENT GROUP LLP (5.9%).
Are Omnicell, Inc. insiders buying or selling?
11 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Omnicell, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.